DCGO on XNAS, Transportation, DocGo Inc., job postings
Measures activity, not value. Not investment advice.
Net loss reached $181.3M over 12 months as institutional holders fell 25%.
WatchLatest quarter revenue up 3.7% to $73.4M, but 12-month revenue down 19%
BadShares fell 72% in six months
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
expected around 15 Mar 2027 (an estimate: a year ago it reported on 16 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $73.4M, net loss $16.6M.
31 Dec 2021RevenueNet incomeNet losstallest bar $199.2M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$73.4M
-$16.6M
30 Jun 2026
$73.4M
-$15.8M
31 Mar 2026
$75.6M
-$14.8M
31 Dec 2025
$74.9M
-$134.1M
30 Sep 2025
$70.8M
-$27.8M
30 Jun 2025
$80.4M
-$11.2M
31 Mar 2025
$96.0M
-$11.1M
31 Dec 2024
$120.8M
-$7.6M
30 Sep 2024
$138.7M
$4.5M
30 Jun 2024
$164.9M
$5.9M
31 Mar 2024
$192.1M
$10.6M
31 Dec 2023
$199.2M
$8.0M
30 Sep 2023
$186.6M
$4.6M
30 Jun 2023
$125.5M
$1.3M
31 Mar 2023
$113.0M
-$3.5M
31 Dec 2022
$108.8M
–
30 Sep 2022
$104.3M
$2.5M
30 Jun 2022
$109.5M
$11.8M
31 Mar 2022
$117.9M
$9.4M
31 Dec 2021
$121.3M
$19.7M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$297.3M
$368.1M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
-19%
+9.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$181.3M
-$56.0M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$1.83
-$0.52
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
18.7%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-53.3%
-22.0%
4.9%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-61.0%
-15.2%
1.0%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-96.5%
-5.7%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$19.1M
$73.4M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
–
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
–
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
1.3
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$1.06
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
16.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.06
2.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
2.7
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
0.16
1.7
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
-25%
87 13F filers vs 116
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
31%
30.4M shares held by 13F filers (30 Sep 2026) of 99.0M outstanding (5 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
2.2%
2.1M shares sold short (30 Oct 2026) of 99.0M outstanding (5 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
3.9
2.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+7.9%
2.0M shares sold short in the report before, 2.1M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
28%
28% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+3.7%
$73.4M vs $70.8M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$20K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
0
0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
–
0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.
Price $0.17 on 20 Nov 2026, -80% over 12 months (12-month range $0.17 to $1.08)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $15K in the last 12 months (the 12 months before: -$57K).Revenue per quarter. Revenue $73.4M in the latest quarter, +3.7% on a year earlier.Capital spending per quarter. Capital spending $121K in the latest quarter.Institutional holders (13F filers). 87 13F filers reported holding it in the latest 13F quarter, -24% on a year earlier.Lobbying spend. Lobbying spend: $20K published in the last 12 months, -50% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.
Quarter ended 31 Mar 2021: $49.7M; public on 11 May 2022
Quarter ended 30 Jun 2021: $62.2M; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $85.8M; public on 9 Nov 2022
Quarter ended 31 Dec 2021: $121.3M; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $117.9M, +137% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $109.5M, +76% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $104.3M, +22% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $108.8M, -10% on a year earlier; public on 15 Mar 2023
Quarter ended 31 Mar 2023: $113.0M, -4.1% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $125.5M, +15% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $186.6M, +79% on a year earlier; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $199.2M, +83% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $192.1M, +70% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $164.9M, +31% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $138.7M, -26% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $120.8M, -39% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $96.0M, -50% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $80.4M, -51% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $70.8M, -49% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $74.9M, -38% on a year earlier; public on 17 Mar 2026
Quarter ended 31 Mar 2026: $75.6M, -21% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $73.4M, -8.7% on a year earlier; public on 18 Aug 2026
Quarter ended 30 Sep 2026: $73.4M, +3.7% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $760K; public on 11 May 2022
Quarter ended 30 Jun 2021: $1.8M; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $243K; public on 9 Nov 2022
Quarter ended 31 Dec 2021: $2.0M; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $602K, -21% on a year earlier; public on 11 May 2022
Quarter ended 31 Dec 2022: $1.2M, -39% on a year earlier; public on 15 Mar 2023
Quarter ended 31 Mar 2023: $2.0M, +228% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $4.8M; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $5.5M; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $3.2M, +168% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $952K, -52% on a year earlier; public on 9 May 2024
Quarter ended 31 Dec 2024: $893K, -72% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $1.5M, +54% on a year earlier; public on 9 May 2025
Quarter ended 31 Mar 2026: $430K, -71% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $321K; public on 18 Aug 2026
Quarter ended 30 Sep 2026: $121K; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 45; public on 14 Feb 2022
31 Mar 2022 report: 66; public on 16 May 2022
30 Jun 2022 report: 85; public on 15 Aug 2022
30 Sep 2022 report: 109; public on 14 Nov 2022
31 Dec 2022 report: 121; public on 14 Feb 2023
31 Mar 2023 report: 137; public on 15 May 2023
30 Jun 2023 report: 134; public on 14 Aug 2023
30 Sep 2023 report: 127; public on 14 Nov 2023
31 Dec 2023 report: 133; public on 14 Feb 2024
31 Mar 2024 report: 131; public on 15 May 2024
30 Jun 2024 report: 119; public on 14 Aug 2024
30 Sep 2024 report: 123; public on 14 Nov 2024
31 Dec 2024 report: 128; public on 14 Feb 2025
31 Mar 2025 report: 131; public on 15 May 2025
30 Jun 2025 report: 116; public on 14 Aug 2025
30 Sep 2025 report: 114; public on 14 Nov 2025
31 Dec 2025 report: 108; public on 17 Feb 2026
31 Mar 2026 report: 118; public on 15 May 2026
30 Jun 2026 report: 116; public on 14 Aug 2026
30 Sep 2026 report: 87; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $10K published
Quarter from 1 Apr 2022: $10K published
Quarter from 1 Jul 2022: $10K published
Quarter from 1 Oct 2022: $10K published
Quarter from 1 Jan 2023: $10K published
Quarter from 1 Apr 2023: $10K published
Quarter from 1 Jul 2023: $10K published
Quarter from 1 Oct 2023: $10K published
Quarter from 1 Jan 2024: $10K published
Quarter from 1 Apr 2024: $10K published
Quarter from 1 Jul 2024: $10K published
Quarter from 1 Oct 2024: $10K published
Quarter from 1 Jan 2025: $10K published
Quarter from 1 Apr 2025: $10K published
Quarter from 1 Jul 2025: $10K published
Quarter from 1 Oct 2025: $10K published
Quarter from 1 Jan 2026: $10K published
Quarter from 1 Apr 2026: $10K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $15K (16 Dec 2025), higher than 41% of its own history.
In 12 months: 2 delisting notices, 2 director or officer changes, 2 major agreements, 1 late report. Results releases and routine reports are left out.
Filed
What happened
Source
13 Nov 2026
CEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing
Reported lobbying spend: $10K in Q1 2026, $10K in Q4 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Two or more unrelated kinds of records unusual within 30 days
19 Mar 2024confirmed
Confirmed across sources Insiders and Filings + Financials
DocGo(DCGO): reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year, while it had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 13 days.
Financials: Quarterly revenue change, became public on 5 Mar 2024
Insiders: Clustered insider buying, became public on 19 Mar 2024
The quarter ended 31 Dec 2023 against the 8 quarters before it.
this quarterearliernormal: $115.4MSee the evidence (2 changes)
Financials: Quarterly revenue change became public on 5 Mar 2024
DocGo reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.
This period
$199.2M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$115.4M
Typical spread (median absolute deviation)
$6.3M
How far from its usual level
+7.3
Same quarter last year
$108.8M
History used
1,005 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
13 Nov 2026Filings change
filed a director or officer change: CEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing.
Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
reported revenue of $192.1M for the quarter ended 31 Mar 2024, 1.7× the same quarter last year.
Same quarter last year: $113.0M; its normal quarter is $115.4M.
See the evidence
This period
$192.1M (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
$115.4M
Typical spread (median absolute deviation)
$8.4M
How far from its usual level
+6.2
Same quarter last year
$113.0M
History used
1,096 days
the quarter ended 31 Mar 20248 earlier quartersnormal: $115.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year, while it had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 13 days.
See the evidence (2 changes)
Financials: Quarterly revenue change became public on 5 Mar 2024
DocGo reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.
This period
$199.2M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$115.4M
Typical spread (median absolute deviation)
$6.3M
How far from its usual level
+7.3
Same quarter last year
$108.8M
History used
1,005 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
19 Mar 2024Insiders change
had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings).
Who bought: Burdiek Michael J, Rosenberg Norman, Katz Steven.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.
Same quarter last year: $108.8M; its normal quarter is $115.4M.
See the evidence
This period
$199.2M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$115.4M
Typical spread (median absolute deviation)
$6.3M
How far from its usual level
+7.3
Same quarter last year
$108.8M
History used
1,005 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $186.6M for the quarter ended 30 Sep 2023, 1.8× the same quarter last year.
Same quarter last year: $104.3M; its normal quarter is $111.3M.
See the evidence
This period
$186.6M (the quarter ended 30 Sep 2023)
Normal quarter (median of 8 earlier)
$111.3M
Typical spread (median absolute deviation)
$6.8M
How far from its usual level
+6.8
Same quarter last year
$104.3M
History used
913 days
the quarter ended 30 Sep 20238 earlier quartersnormal: $111.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Fires on an 8-K with item 5.02 after 90 days without one.
Showing the newest 40 of 59 entries; narrow the window or the kind of data to see older ones.
Not listed: 80 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001822359
Ticker
DCGO
Domain
docgo.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Lobbying client
cardiac rms
Name
AF DE LNZ LLC, AF WI, LLC, AF WI LNZ, LLC, Ambulnz AL, LLC and 54 more
Wikipedia
DocGo
Federal lobbying disclosures (LDA)4 records, 74 data points26 Mar 2020 to 31 Mar 2026
SEC Form 13F institutional holdings189 data points30 Sep 2021 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)90 records25 Sep 2020 to 13 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)322 data points31 Dec 2019 to 5 Nov 2026
SEC Form 4 insider transactions29 records, 88 data points18 May 2023 to 16 Dec 2025
FINRA short interest (twice monthly)357 data points15 Nov 2021 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)2530 data points8 Nov 2021 to 20 Nov 2026
Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026